Cargando…
1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses
OBJECTIVE: Actinic keratoses (AKs) are cutaneous lesions that arise in sun-damaged skin. AKs may transform into squamous cell carcinoma in situ. Tirbanibulin 1% ointment is a new topical treatment for AKs, recently approved by the Food and Drug Administration. DATA SOURCES: The PubMed database was s...
Autores principales: | Dao, Diem-Phuong D., Sahni, Vikram Nath, Sahni, Dev Ram, Balogh, Esther A., Grada, Ayman, Feldman, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899810/ https://www.ncbi.nlm.nih.gov/pubmed/34301153 http://dx.doi.org/10.1177/10600280211031329 |
Ejemplares similares
-
1% Tirbanibulin Ointment for Actinic Keratoses on Upper Extremities: A Retrospective Case Review Study
por: IGLESIAS-PUZAS, Álvaro, et al.
Publicado: (2023) -
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
por: Schlesinger, Todd, et al.
Publicado: (2022) -
Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis
por: Dao, Diem-Phuong, et al.
Publicado: (2021) -
Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease
por: Pleasants, Roy A.
Publicado: (2018) -
Contact Sensitization and Phototoxic and Photoallergic Potential of Tirbanibulin 1% Ointment in Healthy Volunteers
por: Dosik, Jonathan, et al.
Publicado: (2022)